Epidemiology of nosocomial fungal infections, with emphasis on Candida species.
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitAntifungal agents for preventing fungal infections in non-neutropenic critically ill patientsAntifungal agents for preventing fungal infections in non-neutropenic critically-ill patientsPerformance of CHROMAGAR candida and BIGGY agar for identification of yeast speciesRisk factors for fatal candidemia caused by Candida albicans and non-albicans Candida speciesCandida sepsis following transcervical chorionic villi samplingDouble-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsComparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeastsComparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assaysIn vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.An automated high-throughput cell-based multiplexed flow cytometry assay to identify novel compounds to target Candida albicans virulence-related proteinsVisual analysis of DNA microarray data for accurate molecular identification of non-albicans Candida isolates from patients with candidemia episodes.Hospital epidemiology and infection control in acute-care settings.Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.Candida pseudorugosa sp. nov., a novel yeast species from sputum.Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae.Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use.Rapid identification of Candida species with species-specific DNA probesSystematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients.Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans.Evaluation of an immunomagnetic separation method to capture Candida yeasts cells in blood.Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.Prognostic factors for candidaemia in intensive care unit patients: a retrospective analysisLipid-based amphotericin B for the treatment of fungal infections.In vitro and in vivo activities of pterostilbene against Candida albicans biofilms.Candida dubliniensis: characteristics and identification.Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group.Critical evaluation of 4-week incubation for fungal cultures: is the fourth week useful?Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center.A pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans.Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans.Expression, crystallization and preliminary X-ray data analysis of NT-Als9-2, a fungal adhesin from Candida albicans.New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasisPCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies.Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methodsReverse cross blot hybridization assay for rapid detection of PCR-amplified DNA from candida species, Cryptococcus neoformans, and Saccharomyces cerevisiae in clinical samples.Intestinal lesions associated with disseminated candidiasis in an experimental animal model.Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.
P2860
Q21194915-190D8B13-E433-4BF7-8B0B-C50A4E69A159Q24244555-3F9B30F4-4E42-41A9-9D32-079EDBC0F9B2Q24246969-383B5995-C9A4-4825-924F-AACDDFB7B21BQ24797201-F5554FDF-1B86-435F-B1F2-C32EC43D2319Q24799296-7D4C42BD-0856-463C-9093-97980158DE31Q28346543-1F839C1E-E471-4C0D-989A-634AB3EE20AEQ28362691-BD5B4817-D8D3-4B32-B1C2-E954F0AA8930Q28368930-58F57732-2B99-4F44-91D5-8369875E604FQ28378998-C36AE15E-35D4-43D7-A8BF-5699514BD7F2Q28379300-6BEC7BC1-BB45-4F45-AA36-CDD6ED8698FBQ28544418-DB2EF0FD-A3AA-40C1-8D81-07016C790E64Q30391760-034F6C67-7A96-4274-A512-DD9C8819F428Q30429049-7FAEBA8F-F7C8-403D-BAF4-C28E78450E6BQ30452376-40EFA120-AA1C-4365-882C-5C64CAE4C32FQ30994297-7111AB58-0585-4254-A5AE-6A622FCCED35Q31064491-E55DE5F0-943C-4739-89AB-C341647F53A6Q31134433-5F742073-21A2-4B5D-B379-F0F9FD0A2DABQ31918072-704320B5-26E8-4650-87AB-F46752B305BFQ31998547-C6EE27FF-3CC4-4C11-A4BD-2949EB4B4386Q33254158-231958FC-6A54-4B37-B60A-68EFCDB7C934Q33312275-E19CB7BA-8D98-49C9-ABEB-0F1772AADA7CQ33371097-31A42988-163E-4607-A7A4-E6BDDC60D936Q33542339-58D9CF04-78FC-45C1-B27A-795F648A843CQ33567713-B39EFDF9-30CA-4CB8-9570-33668F675FEAQ33604227-65031446-F2A8-4F5F-9B96-94B5DA47EDBEQ33622833-7747E3B7-3ECA-43E1-851C-987831275E81Q33655501-10DC43E8-47FC-40C1-A67D-C54DB1A08ECFQ33684486-111218D3-2269-4590-BD84-941E331E5BAEQ33686511-DD5DDC20-DBA8-4D7D-A7BF-D5AA59DED7ACQ33691981-F3FFFD95-8C36-41D2-9D8F-393B131FB01DQ33709290-E3B4FB39-690F-498E-8F6B-8B43F881CBB7Q33770019-1C32E2D8-A8E4-4C87-BAA9-CD22333A981CQ33788125-6C39899C-4786-4310-9BD1-512DA444A429Q33877204-F4F024AB-6509-4D84-9402-97DF401A0772Q33960316-C192C064-2ECD-4BFB-9DA6-1AA57F0BCC58Q33960914-E28B5C82-C7E7-4B8D-B465-913A264C17BDQ33961413-58F213CC-5EE6-4364-9807-AEA74424FF21Q33966544-5223DBC6-6E09-4740-9979-BA4DB9203B4EQ33967498-900DEE64-9DBF-46FD-B810-2C7B78E80DABQ33971521-5DD4FD6C-FB88-4400-A2B3-50A1D1D159FE
P2860
Epidemiology of nosocomial fungal infections, with emphasis on Candida species.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Epidemiology of nosocomial fungal infections, with emphasis on Candida species.
@en
type
label
Epidemiology of nosocomial fungal infections, with emphasis on Candida species.
@en
prefLabel
Epidemiology of nosocomial fungal infections, with emphasis on Candida species.
@en
P356
P1476
Epidemiology of nosocomial fungal infections, with emphasis on Candida species.
@en
P2093
P304
P356
10.1093/CLINIDS/20.6.1526
P407
P577
1995-06-01T00:00:00Z